Chemical Compound Review:
AG-D-27933 1-[4-(1-hydroxy-2-methoxy- ethyl)phenoxy]-3...
Synonyms:
AG-F-98009, ACMC-20d0x3, KST-1B5834, AC1L3GAB, LS-30772, ...
- Metoprolol and alpha-hydroxymetoprolol concentrations and reduction in essential tremor. Gengo, F.M., Ulatowski, J.A., McHugh, W.B. Clin. Pharmacol. Ther. (1984)
- Influence of chronic renal failure on stereoselective metoprolol metabolism in hypertensive patients. Cerqueira, P.M., Coelho, E.B., Geleilete, T.J., Goldman, G.H., Lanchote, V.L. Journal of clinical pharmacology. (2005)
- Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates. Labbé, L., Sirois, C., Pilote, S., Arseneault, M., Robitaille, N.M., Turgeon, J., Hamelin, B.A. Pharmacogenetics (2000)
- The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites. Hoffmann, K.J., Regårdh, C.G., Aurell, M., Ervik, M., Jordö, L. Clinical pharmacokinetics. (1980)
- Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes. Koyama, E., Sohn, D.R., Shin, S.G., Chiba, K., Shin, J.G., Kim, Y.H., Echizen, H., Ishizaki, T. J. Pharmacol. Exp. Ther. (1994)
- Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes. Otton, S.V., Crewe, H.K., Lennard, M.S., Tucker, G.T., Woods, H.F. J. Pharmacol. Exp. Ther. (1988)
- Regioselective and stereoselective oxidation of metoprolol and bufuralol catalyzed by microsomes containing cDNA-expressed human P4502D6. Mautz, D.S., Nelson, W.L., Shen, D.D. Drug Metab. Dispos. (1995)
- Influence of input rate on the stereospecific and nonstereospecific first pass metabolism and pharmacokinetics of metoprolol extended release formulations. Mistry, B., Leslie, J.L., Eddington, N.D. Chirality. (2002)
- Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer. Horai, Y., Fujita, K., Ishizaki, T. Eur. J. Clin. Pharmacol. (1989)
- High-performance liquid chromatographic determination of metoprolol and alpha-hydroxymetoprolol concentrations in human serum, urine, and cerebrospinal fluid. Gengo, F.M., Ziemniak, M.A., Kinkel, W.R., McHugh, W.B. Journal of pharmaceutical sciences. (1984)
- Stereoselective metabolism of metoprolol: enantioselectivity of alpha-hydroxymetoprolol in plasma and urine. Cerqueira, P.M., Cesarino, E.J., Bertucci, C., Bonato, P.S., Lanchote, V.L. Chirality. (2003)
- Effects and pharmacokinetics of high dose metoprolol on chest pain in patients with suspected or definite acute myocardial infarction. Everts, B., Karlson, B.W., Herlitz, J., Abdon, N.J., Hedner, T. Eur. J. Clin. Pharmacol. (1997)
- Determination of metoprolol and alpha-hydroxymetoprolol in plasma by high-performance liquid chromatography. Pautler, D.B., Jusko, W.J. J. Chromatogr. (1982)
- Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Godbillon, J., Evard, D., Vidon, N., Duval, M., Schoeller, J.P., Bernier, J.J., Hirtz, J. British journal of clinical pharmacology. (1985)